AKTX insider buying and SEC filings, explained
Akari Therapeutics Plc · CIK 1541157
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Dec 16, 2025 | Other purchase | James R Neal (Director) bought 11,132 Pre-Funded Warrants to purchase ADRs in 3 share classes at $0.4000 ($2K for the 5,566 shares with a reported price) in a private placement. New position of 3,093 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 16, 2026 |
| Dec 16, 2025 | Other purchase | Raymond Prudo-Chlebosz (Director) bought 2,010,638 Pre-Funded Warrants to purchase ADRs in 3 share classes at $0.4000 ($402K for the 1,005,319 shares with a reported price) in a private placement. New position of 386,661 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 18, 2025 |
| Dec 16, 2025 | Other purchase | Sandip I Patel (Director) bought 804,252 Pre-Funded Warrants to purchase ADRs in 3 share classes at $0.4000 ($161K for the 402,126 shares with a reported price) in a private placement. New position of 154,664 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 18, 2025 |
| Dec 16, 2025 | Other purchase | Hoyoung Huh (Director and 10% owner) bought 7,423,902 Pre-Funded Warrants to purchase ADRs in 3 share classes at $0.4000 ($1.5M for the 3,711,951 shares with a reported price) in a private placement. New position of 3,093,293 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 18, 2025 |
| Dec 16, 2025 | Other purchase | Kameel D. Farag (CFO) bought 49,490 Pre-Funded Warrants to purchase ADRs in 2 share classes at $0.4000 ($10K for the 24,745 shares with a reported price) in a private placement. New position of 24,745 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 18, 2025 |
| Dec 16, 2025 | Other purchase | Samir Rashmikant Patel (Director and 10% owner) bought 1,701,310 Pre-Funded Warrants to purchase ADRs in 3 share classes directly and indirectly (by entity) at $0.4000 ($340K for the 850,655 shares with a reported price) in a private placement. New position of 618,658 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 18, 2025 |
| Dec 16, 2025 | Other purchase | Abizer Gaslightwala (CEO and Director) bought 2,165,302 Pre-Funded Warrants to purchase ADRs in 3 share classes at $0.4000 ($433K for the 1,082,651 shares with a reported price) in a private placement. New position of 773,323 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 18, 2025 |
| Dec 16, 2025 | Other purchase | Robert B Bazemore (Director) bought 309,326 Pre-Funded Warrants to purchase ADRs in 3 share classes at $0.4000 ($62K for the 154,663 shares with a reported price) in a private placement. New position of 30,932 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 18, 2025 |
14 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow AKTX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.